Mednet Logo
CommunityNeurology

What leads you to consider a non-oral form of levodopa for the treatment of Parkinson’s disease?

In light of new findings on the efficacy of continuous subcutaneous levodopa-carbidopa infusion (Espay et al., PMID 38499015).
2 Answers
Mednet Member
Mednet Member
Neurology · University of Texas Rio Grande Valley
Answered on

I agree with Dr. @Dr. First Last's excellent review.

Consider non-oral forms of medication when there are concerns about dysphagia. Additionally, if the dosing frequency becomes too high (e.g., five times a day of levodopa), and the patient finds it difficult to maintain this schedule, consider long...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Neurology · SUNY Downstate Health Sciences University
Answered on

At the moment, most levodopa formulations are oral medications. There are two non-oral forms of levodopa that are currently in clinical use; an inhalation powder and a continuous enteral solution.

The levodopa inhalation powder is a rescue, on-demand medication used as needed for OFF periods. Given ...

Join for free or sign in to see the full answer